Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Irene eLangner"'
Autor:
Rickard eMalmstrom, Brian eGodman, Eduardo eDiogene, Christoph eBaumgaertel, Marion eBennie, Iain eBishop, Anna eBrzezinska, Anna eBucsics, Stephen eCampbell, Alessandra eFerrario, Alexander eFinlayson, Jurij eFurst, Kristina eGaruoliene, Miguel eGomes, Iñaki eGutiérrez-Ibarluzea, Alan eHaycox, Krystyna eHviding, Harald eHerholz, Mikael eHoffmann, Saira eJan, Jan eJones, Roberta eJoppi, Marija eKalaba, Christina eKvalheim, Ott eLaius, Irene eLangner, Julie eLonsdale, Sven-Ake eLoov, Kamila eMalinowska, Laura eMcCullagh, Ken ePaterson, Vanda eMarkovic-Pekovic, Andrew eMartin, Jutta ePiessnegger, Gisbert eSelke, Catherine eSermet, Steven eSimoens, Faik Cankat Tulunay, Dominik eTomek, Luka eVoncina, Vera eVlahovic-Palcevski, Janet eWale, Michael eWilcock, Magda eWladysiuk, Menno van Woerkom, Corrine eZara, Lars L Gustafsson
Publikováno v:
Frontiers in Pharmacology, Vol 4 (2013)
Background: There are potential conflicts between authorities and companies to fund new premium priced drugs especially where there are safety and/ or budget concerns. Dabigatran, a new oral anticoagulant for the prevention of stroke in patients with
Externí odkaz:
https://doaj.org/article/ddc4fb6f64674453bbdb1706aa447bdf
